tiprankstipranks
Paradigm Biopharmaceuticals Ltd. (PBIGF)
OTHER OTC:PBIGF
US Market
PBIGF
Paradigm Biopharmaceuticals
RESEARCH TOOLSreports

Paradigm Biopharmaceuticals (PBIGF) Financial Statements

17 Followers

Paradigm Biopharmaceuticals Financial Overview

Paradigm Biopharmaceuticals's market cap is currently $96.30M. The company's EPS TTM is $-0.1523; its P/E ratio is -1.64; Paradigm Biopharmaceuticals is scheduled to report earnings on August 21, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 26Jun 25Jun 24Jun 23Jun 22
Income Statement
Total RevenueAU$ 80.15KAU$ 52.12KAU$ 65.80KAU$ 46.76KAU$ 79.22K
Gross ProfitAU$ -82.37KAU$ -19.89KAU$ 56.81KAU$ -18.83KAU$ -64.53K
Operating IncomeAU$ -61.11MAU$ -22.89MAU$ -65.19MAU$ -59.22MAU$ -47.01M
EBITDAAU$ -60.96MAU$ -25.25MAU$ -64.54MAU$ -59.06MAU$ -46.82M
Net IncomeAU$ -56.33MAU$ -18.77MAU$ -58.65MAU$ -51.91MAU$ -39.25M
Balance Sheet
Cash & Short-Term InvestmentsAU$ 15.44MAU$ 16.82MAU$ 17.87MAU$ 56.38MAU$ 39.72M
Total AssetsAU$ 30.55MAU$ 24.57MAU$ 27.39MAU$ 67.07MAU$ 50.69M
Total DebtAU$ 7.51MAU$ 5.48KAU$ 239.33KAU$ 341.67KAU$ 616.67K
Net DebtAU$ -7.86MAU$ -16.81MAU$ -17.58MAU$ -55.99MAU$ -39.06M
Total LiabilitiesAU$ 27.08MAU$ 3.39MAU$ 3.58MAU$ 13.39MAU$ 8.38M
Stockholders' EquityAU$ 3.47MAU$ 21.18MAU$ 23.81MAU$ 53.68MAU$ 42.31M
Cash Flow
Free Cash FlowAU$ -43.69MAU$ -15.99MAU$ -65.94MAU$ -45.19MAU$ -32.21M
Operating Cash FlowAU$ -43.69MAU$ -15.99MAU$ -65.94MAU$ -45.19MAU$ -32.21M
Investing Cash FlowAU$ -552.32KAU$ 46.20KAU$ 0.00AU$ 0.00AU$ 0.00
Financing Cash FlowAU$ 43.69MAU$ 14.99MAU$ 28.18MAU$ 62.53MAU$ 70.12K
Currency in AUD

Paradigm Biopharmaceuticals Earnings and Revenue History

Income Statement >

Paradigm Biopharmaceuticals Debt to Assets

Balance Sheet >

Paradigm Biopharmaceuticals Cash Flow

Cash Flow >

Paradigm Biopharmaceuticals Forecast EPS vs Actual EPS

Earnings >